Dr. Abderrahim is an Associate Professor of Biostatistics and the acting chair of the Department of Epidemiology and Public Health at Khalifa University. He has over 28 years of experience in academia and research. He is serving as the director of the KU-SEHA clinical research certificate program managing and providing clinical research skills to over 140 residents and fellows from all public hospitals and clinics in Abu Dhabi. Dr. Abderrahim holds a PhD degree in statistics from UCL University (2003, Belgium). He worked at the United Arab Emirates University (UAEU) as an Associate Professor of Biostatistics for 8 years where he served as the director of the PhD program in Public Health. Prior to joining the UAEU, he worked as a senior statistician at the University of Oxford for almost 10 years. During this period, he was the lead biostatistician for several projects including the Oxford Project to Investigate Memory and Ageing (OPTIMA), and the EXenatide Study of Cardiovascular Event Lowering (EXSCEL), both at the University of Oxford (UK). Dr. Abderrahim has served on many national and international research committees. He’s currently a project lead at the scientific group of the European Society of Cardiology, Cardiovascular Risk Collaboration Unit. He also has served in several UAE national committees including the therapeutic and clinical trials, the epidemiology, the diagnostic, and the data safety and monitoring board committees. He also contributed to the development of two national guidelines for cardiovascular disease prevention in collaboration with the Department of Health’s Weqaya screening program consultation group.
Dr. Abderrahim Oulhaj has received many awards from UAE for excellence in research by publishing in top peer-reviewed scientific journals. He has 3 international patents and copyrights in the area of Alzheimer’s disease. His research of interest involves statistical modelling of medical and health data in infectious and chronic diseases, especially Diabetes, Cardiovascular diseases, Neurodegenerative diseases, COPD, and recently COVID-19. Dr Aberrahim’s current research of interests includes Survival analysis, Risk predictions modelling, Longitudinal data analysis, Machine and deep learning, and Joint modelling of repeated measures and time-to-event data.
